The state of California currently has 8 active clinical trials seeking participants for Weight Loss research studies. These trials are conducted in various cities, including Los Angeles, San Francisco, San Diego and Sacramento.
Community-based CBT and T2D in Latino Population
Recruiting
The purpose of this project is to develop and test the acceptance and clinical efficacy of a cognitive behavioral therapy (CBT)-based lifestyle intervention, to help manage obesity and diabetes-related health outcomes, provided through community health workers (CHWs) in Latino adults with type 2 diabetes (T2D). A collaboration with an established community-based organization named Sansum Diabetes Research Institute (SDRI), will provide an opportunity to develop, train and implement a culturally... Read More
Gender:
All
Ages:
Between 35 years and 65 years
Trial Updated:
03/07/2024
Locations: Sansum Diabetes Research Institute, Santa Barbara, California
Conditions: Type 2 Diabetes, Mental Health Issue, Quality of Life, Weight Loss
Signos DM2 Empowerment Study (SIGNOS-CGM-EMPOWER-201-2022)
Recruiting
The use of continuous glucose monitoring (CGM) in earlier data has inspired behavioral changes leading to improved adherence to an exercise plan in individuals and eating habits in people with diabetes. Mobile health (mHealth) platforms provide satisfactory, easy-to-use tools to help participants in the pursuit of weight change goals. We hypothesize that the use of CGM data and the Signos mHealth platform will assist with weight control in a population of people with type 2 diabetes mellitus who... Read More
Gender:
All
Ages:
18 years and above
Trial Updated:
01/10/2024
Locations: Signos, Palo Alto, California
Conditions: Weight Loss, Metabolic Syndrome, Diabetes Mellitus, Type 2, Central Obesity, Insulin Resistance, Glucose Intolerance, Metabolic Glucose Disorders
Spark: Finding the Optimal Tracking Strategy for Weight Loss in a Digital Health Intervention
Recruiting
This optimization trial will examine three tracking (or "self-monitoring") strategies for weight loss -- tracking dietary intake, steps, and/or body weight -- all delivered through digital health tools. The purpose of the study is to evaluate the combination of these strategies that maximizes 6-month weight loss in the context of a standalone digital health intervention for adults with overweight or obesity. The investigators will recruit 176 total participants to the trial. Recruitment will oc... Read More
Gender:
All
Ages:
18 years and above
Trial Updated:
01/05/2024
Locations: Stanford University School of Medicine, Stanford, California
Conditions: Obesity, Overweight, Weight Loss, Health Behavior
BrainWeighve Weight Loss App
Recruiting
Childhood obesity within the United States has been a growing concern over the past number of years, and if not addressed, leads to detrimental health outcomes for youth as they move into adulthood. The literature suggests that over-eating, especially when framed in terms of food addiction, plays a key role in this epidemic; however, treatment options are time intensive, posing a profound logistical barrier for both the child and parent and often limits or prevents engagement. As research within... Read More
Gender:
All
Ages:
Between 14 years and 18 years
Trial Updated:
11/21/2023
Locations: UCLA Integrated Substance Abuse Programs, Los Angeles, California
Conditions: Weight Loss
VK2735 for Weight Management Phase 2
Recruiting
This is a phase 2, 13-week randomized, double-blind, placebo-controlled, parallel arm study that will evaluate the safety, tolerability, weight loss efficacy, pharmacodynamic effects, and pharmacokinetics of VK2735 in adults who are obese (BMI ≥30 kg/m2) or who are overweight (BMI ≥27 kg/m2) with at least one weight-related co-morbid condition. VK2735 or matched placebo will be administered once weekly.
Gender:
All
Ages:
18 years and above
Trial Updated:
09/28/2023
Locations: Viking Clinical Site #114, Long Beach, California +2 locations
Conditions: Weight Loss
Latino Semaglutide Study
Recruiting
The purpose of this study to understand better how this anti-obesity medication works to assist individuals to lose weight and maintain weight loss. This study may lead to the development of other related medications for assisting people with the disease of obesity.
Gender:
All
Ages:
Between 18 years and 75 years
Trial Updated:
06/07/2023
Locations: Loma Linda University Health, Loma Linda, California
Conditions: Obesity, Obesity; Drug, Overweight or Obesity, Weight Loss, Weight Loss Trajectory, Weight, Body
Use of Continuous Glucose Monitoring in Non-Diabetic Population to Compliment Signos Mobile Health Platform
Recruiting
Metabolic syndrome and resulting downstream health effects remains a growing health concern. In published trials, the use of continuous glucose monitoring (CGM) assists behavioral changes efforts, leading to improved adherence and results from diet and exercise changes in individuals with obesity, pre-diabetes and diabetes. Mobile health (mHealth) platforms provide satisfactory, easy-to-use tools that help participants in the pursuit of weight change goals. We hypothesize that the use of CGM dat... Read More
Gender:
All
Ages:
18 years and above
Trial Updated:
05/16/2023
Locations: Signos, Palo Alto, California
Conditions: Weight Loss, Metabolic Syndrome, Pre-diabetes, Central Obesity, Glucose Intolerance, Metabolic Glucose Disorders
Outcomes After Weight Loss Surgery in Low-Risk Patients
Recruiting
The purpose of this research is to determine patient-reported outcomes after weight loss surgery, including changes in health, mood, quality of life, health satisfaction, and emotional health, in low-risk patients. Weight loss surgery has been well studied for patients with body mass index (BMI) 35 kg/m^2 or more and those with weight-related medical problems who have a BMI 30 kg/m^2 or more. However, outcomes after weight loss surgery in patients with BMI under 35 kg/m^2 and without co-morbidit... Read More
Gender:
All
Ages:
All
Trial Updated:
01/24/2023
Locations: Dr. Feiz and Associates, Beverly Hills, California
Conditions: Weight Loss, Bariatric Surgery